Answers are grounded in this paper and cite their sources.
Background: Delay in COVID-19 diagnosis due to late real-time reverse transcription-polymerase chain reaction reporting has been described to be an important cause of suboptimal COVID-19 surveillance and outbreak containment.Objective:The objective of the study was to determine the duration of diagnostic delay due to test turnaround time and its association with marginalization status.Methods: In this observational study using national open data of Mexico and Colombia, we quantified the delay in COVID-19 diagnosis that occurred in both countries.We considered two periods that contributed to the delay in diagnosis: the time from symptom onset until testing (delay-one) and test turnaround time (delay-two).Marginalization status was determined according to country-specific scores.Results: Among 3,696,773 patients from Mexico and Colombia, delay-two was generally longer than delay-one.Median delay-one was 3 days and delay-two 7 days in Colombia, while in Mexico, they were 3 days and 4 days, respectively.In Colombia, worse marginalization status prolonged delaytwo.In Mexico, a lower number and percentage of rapid tests were performed in areas with worse marginalization.Conclusion: Diagnostic delay was mostly due to test turnaround time.Marginalization status was an important barrier to diagnostic test access.(REV INVEST CLIN.2022;74(2):71-80)
No takes yet. Share an insight, caveat, or question.
A 2022 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: